Maxitrol

Medicinal product

(Invented) name

Maxitrol

Active substance (s)

Deksametazonas/Neomicino sulfatas/Polimiksino B sulfatas

Strength

1 mg/3500 TV/6000 TV/ml

Pharmaceutical form

akių lašai (suspensija)

Route (s) of administration

vartoti ant akių

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

S01CA01, Dexamethasone and antiinfectives

Marketing authorisation holder

SIA Novartis Baltics, Latvija

Date of authorisation

1992-03-05

Date of renewal

2010-07-02

Documents

2087 Pakuotės lapelis akiu lasai 2025 02 01.docx

2087 Maxitrol akiu lasai II PL 2025 02 01.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

1 ml suspensijos yra	1 ml
Deksametazonas	1 mg
Neomicino sulfatas	3500 TV
Polimiksino B sulfatas	6000 TV

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
8089	12840	1012840	buteliukas	5 ml (su lašintuvu) N1		Receptinis	LT/1/92/2087/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2010-07-02	Perregistruotas
1992-03-05	Registruotas